Skip to main content
SpringerLink
Log in

High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up

Graefe's Archive for Clinical and Experimental Ophthalmology volume 245, pages 1097–1105 (2007)Cite this article

Abstract

Background

The high-density silicone oil (Densiron 68), a mixture of F6H8 with silicone oil, seems to be a therapeutic option, at least in selected patients with complex inferior retinal re-detachment, where standard procedures have already failed. In an interventional case series we used Densiron as a primary endotamponade.

Methods

Twelve eyes of 12 patients aged 31 years to 85 years with inferior complex rhegmatogenous retinal detachment with secondary proliferative vitreoretinopathy (PVR) grades CP2 to CA8 were included. Surgical techniques (pars plana vitrectomy, membrane peeling, retinotomy, retinectomy, endophotocoagulation, cryocoagulation, endotamponade) did not include a scleral buckling procedure (except one eye). Mean duration of the Densiron endotamponade was 78.3  ±  29.74 days, with a mean follow up after removal of 400.6 ± 85.4 days.

Results

After Densiron removal, four patients (33.3%) showed a stable reattached retina without further interventions, while, in six patients (50%), recurrent retinal re-detachment appeared during endotamponade, generally within 2 months. One patient (8.3%) developed re-detachment 5 months after Densiron removal. One eye (8.3%) lost light perception due to severe intraretinal fibrosis with chronic hypotonia, despite complete retinal re-attachment. Visual acuity improved from mean logarithm of the minimum angle of resolution (logMAR) of 2.95 ± 1.21 to 1.87 ± 1.32 (statistically significant, P = 0.022). Side effects included temporary inflammatory reaction/fibrin accumulation (n = 2/2), moderate-to-severe intraretinal fibrosis (n = 3), elevated intraocular pressure (IOP) (n = 3), emulsification (n = 2), sterile hypopyon (n = 1), vitreous haemorrhage (n = 1) and chronic hypotony (n = 1).

Conclusion

Primary anatomical success rate of 33.3% was less encouraging than as expected. Especially, re-detachments within the posterior staphyloma in highly myopic patients were common during Densiron endotamponade. However, the surgical success increased to 75% after re-intervention, even without the use of an additional encircling band. The observed adverse effects and the functional outcomes do not contraindicate the use of Densiron as an internal tamponade for a period of 3 months.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R (1991) Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 11:367–374

    PubMed  CAS  Google Scholar 

  2. Chang S, Zimmerman NJ, Iwamoto T, Ortiz R, Faris D (1987) Experimental vitreous replacement with perfluorotributylamine. Am J Ophthalmol 103:29–37

    PubMed  CAS  Google Scholar 

  3. Dresp JH, Menz D-H (2005) Interaction of different ocular endotamponades as a risk factor for silicone oil emulsification. Retina 25:902–910

    Article  PubMed  Google Scholar 

  4. Falkner CI, Binder S, Kruger A (2001) Outcome after silicone oil removal. Br J Ophthalmol 85:1324–1327

    Article  PubMed  CAS  Google Scholar 

  5. Fisk MJ, Cairns JD (1995) Silicone oil insertion. A review of 127 consecutive cases. Aust N Z J Ophthalmol 23:25–32

    PubMed  CAS  Google Scholar 

  6. Flaxel CJ, Mitchell SM, Aylward GW (2000) Visual outcome after silicone oil removal and recurrent retinal detachment repair. Eye 14:834–838

    PubMed  CAS  Google Scholar 

  7. Gabel VP, Kampik A, Gabel C, Spiegel D (1987) Silicone oil with high specific gravity for intraocular use. Br J Ophthalmol 71:262–267

    PubMed  CAS  Google Scholar 

  8. Gerding H, Kolck A (2004) [Perfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 months]. Ophthalmologe 101:255–262

    Article  PubMed  CAS  Google Scholar 

  9. Gremillion CM Jr, Peyman GA, Liu KR, Naguib KS (1990) Fluorosilicone oil in the treatment of retinal detachment. Br J Ophthalmol 74:643–646

    PubMed  Google Scholar 

  10. Hiscott P, Magee RM, Colthurst M, Lois N, Wong D (2001) Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade. Br J Ophthalmol 85:179–183

    Article  PubMed  CAS  Google Scholar 

  11. Hoerauf H, Kobuch K, Dresp J, Menz DH (2001) Combined use of partially fluorinated alkanes, perfluorocarbon liquids and silicone oil: an experimental study. Graefes Arch Clin Exp Ophthalmol 239:373–381

    PubMed  CAS  Google Scholar 

  12. Jonas JB, Knorr HL, Rank RM, Budde WM (2001) Retinal redetachment after removal of intraocular silicone oil tamponade. Br J Ophthalmol 85:1203–1207

    Article  PubMed  CAS  Google Scholar 

  13. Kampik A, Hoing C, Heidenkummer HP (1992) Problems and timing in the removal of silicone oil. Retina 12:S11–S16

    Article  PubMed  CAS  Google Scholar 

  14. Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N, Schrage NF (2002) Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 133:95–101

    Article  PubMed  CAS  Google Scholar 

  15. Kobuch K, Menz IH, Hoerauf H, Dresp JH, Gabel VP (2001) New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 239:635–642

    PubMed  CAS  Google Scholar 

  16. La Heij EC, Hendrikse F, Kessels AG (2001) Results and complications of temporary silicone oil tamponade in patients with complicated retinal detachments. Retina 21:107–114

    Article  PubMed  Google Scholar 

  17. Lucke K, Laqua H (1990) Proliferative vitreoretinopathy silicone oil in the treatment of complicated retinal detachments. Springer, Berlin Heidelberg New York, pp 81–88

    Google Scholar 

  18. Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM (1991) An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112:159–165

    PubMed  CAS  Google Scholar 

  19. Malchiodi-Albedi F, Matteucci A, Formisano G, Paradisi S, Carnovale-Scalzo G, Perilli R, Scorcia G, Caiazza S (2003) Perfluorohexyloctane (F6H8) induces structural modifications and increases apoptosis in rat primary retinal cultures. J Biomed Mater Res B Appl Biomater 65:133–136

    Article  PubMed  CAS  Google Scholar 

  20. Meinert H, Roy T (2000) Semifluorinated alkanes—a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol 10:189–197

    PubMed  CAS  Google Scholar 

  21. Mertens S, Bednarz J, Engelmann K (2002) Evidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell types. Graefes Arch Clin Exp Ophthalmol 240:989–995

    CAS  Google Scholar 

  22. Miyamoto K, Refojo MF, Tolentino FI, Fournier GA, Albert DM (1984) Perfluoroether liquid as a long-term vitreous substitute. An experimental study. Retina 4:264–268

    Article  PubMed  CAS  Google Scholar 

  23. Nabih M, Peyman GA, Clark LC Jr, Hoffman RE, Miceli M, Abou-Steit M, Tawakol M, Liu KR (1989) Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: a preliminary report. Ophthalmic Surg 20:286–293

    PubMed  CAS  Google Scholar 

  24. Pastor JC, Mendez MC, de la Fuente MA, Coco RM, Garcia-Arumi J, Rodriguez de la Rua E, Fernandez N, Saornil MA, Gayoso MJ (2006) Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening. Ophthalmic Res 38:193–200

    Article  PubMed  CAS  Google Scholar 

  25. Roider J, Hoerauf H, Kobuch K, Gabel VP (2002) Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 240:965–971

    PubMed  CAS  Google Scholar 

  26. Sandner D, Engelmann K (2006) First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment Graefes Arch Clin Exp Ophthalmol 244:609–619

    Article  PubMed  Google Scholar 

  27. Schatz B, El-Shabrawi Y, Haas A, Langmann G (2004) Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgery. Retina 24:567–573

    Article  PubMed  Google Scholar 

  28. Schatz B, Langmann G, Faulborn J (2001) Erfahrungen mit Fluoron (F6H8) als Tamponade in der komplexen Netzhautchirurgie. Spektrum Augenheilkd 15:238–241

    Article  Google Scholar 

  29. Scott IU, Flynn HW, Lai M, et al (2000) First operation anatomic success and other predictors of postoperative vision after complex retinal detachment repair with vitrectomy and silicone oil tamponade. Am J Ophthalmol 130:745–750

    Article  PubMed  CAS  Google Scholar 

  30. Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG (2005) Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 46:329–342

    Article  PubMed  Google Scholar 

  31. Sharma T, Gopal L, Shanmugam MP, et al (2002) Management of recurrent retinal detachment in silicone oil-filled eyes. Retina 22:153–157

    Article  PubMed  Google Scholar 

  32. Sparrow JR, Matthews GP, Iwamoto T, Ross R, Gershbein A, Chang S (1993) Retinal tolerance to intravitreal perfluoroethylcyclohexane liquid in the rabbit. Retina 13:56–62

    Article  PubMed  CAS  Google Scholar 

  33. Stolba U, Krepler K, Pflug R, Velikay M, Wedrich A, Binder S (1997) Experimental vitreous and aqueous replacement with perfluorophenanthrene. Clinical, histologic, and electrophysiologic results. Retina 17:146–153

    Article  PubMed  CAS  Google Scholar 

  34. Stolba U, Krepler K, Velikay-Parel M, Binder S (2004) The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. Graefes Arch Clin Exp Ophthalmol 242:931–936

    Article  PubMed  Google Scholar 

  35. Theelen T, Tilanus M, Klevering BJ (2004) Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol 242:617–620

    PubMed  CAS  Google Scholar 

  36. Tognetto D, Minutola D, Sanguinetti G, Ravalico G (2005) Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: a pilot study. Ophthalmology 112:1574–1578, Sep

    Article  PubMed  Google Scholar 

  37. Velikay M, Wedrich A, Stolba U, Datlinger P, Li Y, Binder S (1993) Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin. Am J Ophthalmol 116:565–570

    PubMed  CAS  Google Scholar 

  38. Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A (2003) Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Exp Ophthalmol 31:408–414

    Article  Google Scholar 

  39. Wolf S, Schon V, Meier P, Wiedemann P (2003) Silicone oil-RMN3 mixture (“heavy silicone oil”) as internal tamponade for complicated retinal detachment. Retina 23:335–342

    Article  PubMed  Google Scholar 

  40. Wong D, Van Meurs JC, et al (2005) A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 89:662–665

    Article  PubMed  CAS  Google Scholar 

  41. Wong D, Williams R, Stappler T, Groenewald C (2005) What pressure is exerted on the retina by heavy tamponade agents? Graefes Arch Clin Exp Ophthalmol 243:474–477

    Article  PubMed  Google Scholar 

  42. Yamamoto S, Takeuchi S (2000) Silicone oil and fluorosilicone. Semin Ophthalmol 15:15–24

    Article  PubMed  CAS  Google Scholar 

  43. Zeana D, Becker J, Kuckelkorn R, Kirchhof B (1999) Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 23:17–24

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Medical Faculty “Carl Gustav Carus”, Dresden University of Technology, Fetscherstrasse 74, 01307, Dresden, Germany

    Dirk Sandner & Erdmuth Herbrig

  2. Department of Ophthalmology, Chemnitz Clinical Centre, Chemnitz, Germany

    Katrin Engelmann

Authors
  1. Dirk Sandner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erdmuth Herbrig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katrin Engelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dirk Sandner.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sandner, D., Herbrig, E. & Engelmann, K. High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol 245, 1097–1105 (2007). https://doi.org/10.1007/s00417-006-0496-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-006-0496-y

Keywords

search

Navigation